Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional

The Safety and Efficacy of an Investigational Drug in Delaying the Progression of Alzheimer's Disease

ClinicalTrials.gov ID: NCT00006187

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT00006187. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 18, 2026, 4:19 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a 15-month study with two phases. During the first 12-month phase of this study, patients will be randomly assigned to receive either active study drug or placebo (approximately half of all patients will be on active study drug, the other half on placebo). The second phase is a 3-month randomized withdrawal period. For this phase approximately 10% of the patients will remain on the active drug.

Study identification

NCT ID
NCT00006187
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Merck Sharp & Dohme LLC
Industry
Enrollment
Not listed

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
50 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Not listed
Primary completion
Jun 2005 (Estimated)
Completion
Jun 2005 (Estimated)
Last update posted
Dec 11, 2009

Ends 2005

United States locations

U.S. sites
34
U.S. states
16
U.S. cities
32
Facility City State ZIP Site status
Pivotal Research Centers Peoria Arizona 85381 —
California Clinical Trials Beverly Hills California 90211 —
Pharmacology Research Institute Los Alamitos California 90720 —
Pharmacology Research Institute Newport Beach California 92660 —
Daniel Grosz MD Northridge California 91324 —
Pharmacology Research Institute Riverside California 92506 —
Pacific Research Network San Diego California 92103 —
San Francisco Headache Clinic San Francisco California 94109 —
Yale University, Alzheimer's Disease ResearchUnit New Haven Connecticut 06520-8037 —
New England Center for Headache Stamford Connecticut 06902 —
Baumel-Eisner Neuromedical Institute Boca Raton Florida 33486 —
Baumel-Eisner Neuromedical Institute Fort Lauderdale Florida 33321 —
ICSL Clinical Studies Fort Myers Florida 33907 —
ICSL Clinical Studies Melbourne Florida 32935 —
ICSL Clinical Studies Sarasota Florida 34232 —
ICSL Clinical Studies St. Petersburg Florida 33702 —
Meridien Research St. Petersburg Florida 33710 —
Premiere Research Institute West Palm Beach Florida 33407 —
Palm Beach Neurological Center West Palm Beach Florida 33410 —
Chicago Center for Clinical Research Chicago Illinois 60610 —
ICSL Clinical Studies South Yarmouth Massachusetts 02664 —
Las Vegas Center for Clinical Research Las Vegas Nevada 89146 —
Nathan Klein Institute Orangeburg New York 10962 —
University of Rochester Rochester New York 14620 —
Piedmont Medical Research Associates Winston-Salem North Carolina 27103 —
Pahl Brain Associates, P.C. Oklahoma City Oklahoma 73118 —
Clinical Pharmaceutical Trials Tulsa Oklahoma 74104-5428 —
Pacific NW Clinical Research Center Portland Oregon 97223 —
Institute for Advanced Clinical Research Elkins Park Pennsylvania 19027 —
ICSL Clinical Studies Philadelphia Pennsylvania 19106 —
ICSL Clinical Studies East Providence Rhode Island 02915 —
Pharmacology Research Clinic Salt Lake City Utah 84107 —
Seattle Clinical Research Center Seattle Washington 98104 —
Froedtert Lutheran Memorial Hospital Milwaukee Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00006187, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 11, 2009 · Synced Nov 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.